Oncotest

Do I have cancer? If so, what kind of cancer do I have? How many cancers have recommended screening? Watch Professor Eitan Friedman and Professor Ido Wolf discuss the answers to these questions and the importance of early detection. With Galleri Test, there is finally a test that can detect a cancer signal shared by 50+ types of cancer — so you can take action before symptoms appear. Discover the advantages of Galleri, a multi-cancer early detection test. To learn more, please visit https://oncotest.co.il The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. #early_detection #oncology #screening #Oncotest #Grail

Wishing you a Happy New Year from all of us at Oncotest! May this year be filled with new opportunities, meaningful collaborations, and continued growth. #HappyNewYear #Oncotest #2025

Oncotest invites you to join us for our upcoming webinar: "CureMatch Solution for Navigating Molecular Cancer Complexity" 📅 Tuesday, January 21st | 12:30 PM CT Gain insights from Prof. Razelle Kurzrock, MD, FACP (Co-Founder, Board of Directors, and Chief Medical Officer at CureMatch, Inc.) as she discusses how CureMatch personalizes cancer treatment. Learn how the innovative platform matches patient's unique molecular markers to FDA/EMA-approved drugs and enables tailored drug combinations which help address as many biomarkers as possible in order to fight each patient’s cancer. Register here: https://lnkd.in/dxZxUych #webinar #curematch #cancer

לראשונה בישראל ניתן לבצע בדיקת דם שיכולה לאתר חמישים סוגים של סרטן בשלב מוקדם ובכך לשפר את הסיכוי להציל חיים. לקריאת הכתבה >>https://lnkd.in/d3nTGr56

אונקוטסט גאה להשיק לראשונה בישראל את בדיקת "גלרי" (Galleri) - הבדיקה הראשונה והיחידה מסוגה בעולם לגילוי מוקדם של 50 סוגי סרטן באמצעות דגימת דם. הבדיקה מיועדת לאנשים בסיכון מוגבר לחלות בסרטן כגון בני חמישים ומעלה; בעלי היסטוריה משפחתית מקרבה ראשונה של סרטן ועוד. אבחון מוקדם מציל חיים ויכול לשפר משמעותית את סיכויי ההישרדות, להקל על תהליך הטיפול, ולשפר את איכות החיים של החולה. צפו בכתבה על הבדיקה ששודרה במהדורה המרכזית בחדשות 12. לפרטים נוספים >> https://bit.ly/41QMchV #Galleri #EarlyDetection #InnovationInHealthcare #CancerScreening

20 years of the Oncotype DX Breast Recurrence Score® Test. Yesterday, Oncotest proudly hosted an event marking 20 years of the Oncotype DX Breast Recurrence Score® Test at the Steinhardt Museum of Natural History in Tel Aviv. We were honored to hear from: Dr. Christy A. Russell, MD, Vice President of US Medical Affairs at Exact Sciences, who shared insights on the impact and advancements of Oncotype DX Breast Recurrence Score® Test over the years, as well as recent updates. Prof. Salomon M Stemmer, MD, who presented groundbreaking studies based on Clalit Registry data which played a crucial role in shaping Oncotype DX Breast Recurrence Score® Test influence on clinical practice and personalized care. We are grateful to everyone who joined us to celebrate this milestone and look forward to continuing our mission of advancing precision oncology. Here's to 20 more years of transforming care! #Oncotest #OncotypeDX #ExactSciences #PrecisionOncology #BreastCancer #HealthcareInnovation

Supporting Women's Health: BRCA Carriers Follow-Up – A Look to the Future Yesterday, we had the privilege of participating in the The Meirav Breast Cancer Center's event on "BRCA Carriers Follow-Up – Updates and a Look to the Future" held at the Sourasky Center, Sheba Medical Center. At Oncotest, we are proud to be part of the ongoing effort to advance women’s health and support innovative initiatives like this.   The event covered fascinating and important topics regarding risk management and medical follow-up for BRCA carriers, including: advances in imaging, nutrition and health in high-risk women, implications of surgical menopause following ovary removal, physical activity and cancer risk reduction, advances in early detection of ovarian cancer, risk of additional cancers and future monitoring strategies, and more. The conference highlighted the importance of combining medical innovation, advanced research, and personal guidance in managing BRCA-related risks. It was clear how the continued support of decision-making throughout the journey was at the heart of the Meirav Breast Cancer Center's great team.   A big thank you to the organizers and everyone who contributed to this special evening.

  Participating in an Empowering Gathering on Young Women and Breast Cancer This past Friday, we had the privilege of attending an inspiring and impactful meeting for young women dealing with breast cancer hosted by The Jusidman Cancer Center, Sheba Medical Centre. The event brought together oncologists, breast cancer survivors, coordinating nurses and experts in fertility preservation and sexuality to discuss a range of important topics, including fertility and pregnancy, sexuality and recovery process after breast cancer, as well as the emotional aspects of the journey. It was truly moving to hear the personal stories of resilience, strength, and hope shared by the survivors. At Oncotest, we feel deeply connected to the mission of supporting patients not only through innovative tests for personalized oncology but also through supporting a platform for discussions that bring the patient to the forefront, while acknowledging the unique needs of young women who are navigating the complexities of breast cancer. Thank you to the organizers, speakers, and all the participants who made this event so special and moving.   #BreastCancer #PatientSupport #FertilityAfterCancer #MaternityAfterCancer #Recovery #SexualHealth #Oncology #WomenEmpowerment

חברת אונקוטסט גאה לתמוך בכנס הישראלי התשיעי לגידולי מערכת העיכול בחסות האיגוד הישראלי לאונקולוגיה קלינית ורדיותרפיה. פרופ' ברוך ברנר מהמרכז הרפואי דוידוף, יציג את המחקר הישראלי בנושא : Treatments and outcomes using the Oncotype DX® Colon Recurrence Score in stage II colon cancer מחקר זה הינו מחקר מעקב מהעולם האמיתי שהתבצע במסגרת שרותי בריאות כללית , בנוסף למחקרי מעקב רבים שהתבצעו עם שימוש בבדיקות אונקוטייפ שד וקולון שתרומתם מהווה אבן דרך משמעותית בהבנת הגישה הגנומית בטיפול בסרטן השד והמעי הגס. אונקוטסט תמשיך לפעול לקידום המודעות והמחקר בתחום בדיקות גנומיות לסרטן, לטובת שיפור חיי המטופלים.   #אונקוטסט #גידולי_מעי #סרטן #בדיקות_גנומיות #אונקוטייפ_קולון  

Yesterday, we proudly hosted the *2nd Israeli Oncomine Round Table*, bringing together pathology institute leadership and professionals from 17 molecular pathology labs across Israel. This inspiring event highlighted the importance of partnership in delivering cutting-edge molecular tests for oncology patients.   With the strong backing of Thermo-Fisher Scientific, we featured expert speakers on hot topics and innovative Oncomine panels. The event ended with a *round table session*, where challenges, and future aspirations were discussed with Thermo-Fisher's Medical Affairs team.   A heartfelt thank you to all attendees for their engagement and to our partners at Thermo-Fisher Philip Jermann Chris Allen Ilan Vered for helping us create a space for collaboration and dialogue. Together, we are building a stronger, more innovative future for precision medicine oncology.  #Oncology #MolecularPathology #Leadership #Collaboration #Innovation #Oncomine